EGFR Resisters
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
EGFR Resisters
May 9, 2024, 14:30 |
Blog
Jill Feldman: Dosing studies are critical!
Jill Feldman, Co-Founder of EGFR Resisters, shared a post on X: "Dosing studies are critical! OS…
Apr 15, 2024, 13:05 |
Blog
Jill Feldman: A must-attend educational session at ASCO24
Jill Feldman shared a post on X: "Words couldn't be more true - In the era…
Mar 25, 2024, 12:26 |
Blog
Jill Feldman: It is a tremendous honor for the EGFR Resisters to be nominated for the Healio HemOnc Today Patient Voice award among these esteemed organizations
Jill Feldman, Co-Founder of EGFR Resisters, shared a post by Healio on LinkedIn, adding: "It…
Mar 24, 2024, 13:03 |
Career
Jill Feldman Awarded the 2024 ASCO Patient Advocate Award
The American Society of Clinical Oncology (ASCO) has announced Jill Feldman, as the recipient of the 2024 ASCO…
Mar 9, 2024, 19:24 |
Blog
11 posts not to miss from International Women's Day 2024
International Women's Day is celebrated annually on March 8th. Below are featured some of the…
Feb 13, 2024, 18:54 |
Opinion
Jill Feldman: It's the era of patient-centered ‘everything’ and patients are the ONLY ones who can define what that means
Jill Feldman shared Fumiko Ladd Chino's post on X/Twitter, adding: "It's the era of patient-centered ‘everything’…
Feb 10, 2024, 19:00 |
Insight
Jill Feldman: We must try to be ‘precise’ with dosing so people can LIVE better
Jill Feldman shared on X/Twitter: "Thank you, Associated Press for this story on dosing! No…
Jan 26, 2024, 18:13 |
Blog
Jill Feldman: This picture is worth a thousand words!
Jill Feldman recently shared a post on her LinkedIn page: "This picture is worth a…
Jan 13, 2024, 10:04 |
Blog
Nathan A. Pennell: Pralsetinib development outside the US and China also stopped
Nathan A. Pennell, Co-Director of the Cleveland Clinic Lung Cancer Program, shared a post by…
Jan 8, 2024, 14:37 |
Blog
A 32-year-old lung cancer survivor, mother of 2 and oncology nurse practitioner - EGFR Resisters
EGFR Resisters shared a post on X/Twitter: "Meet Caroline, A 32-year-old lung cancer survivor, mother…
1
2
All:
12
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube